382 related articles for article (PubMed ID: 2565384)
21. Antisecretory and antiulcer effect of the H2-receptor antagonist famotidine in the rat: comparison with ranitidine.
Scarpignato C; Tramacere R; Zappia L
Br J Pharmacol; 1987 Sep; 92(1):153-9. PubMed ID: 2889492
[TBL] [Abstract][Full Text] [Related]
22. Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.
Pendleton RG; Torchiana ML; Chung C; Cook P; Wiese S; Clineschmidt BV
Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):4-16. PubMed ID: 6141772
[TBL] [Abstract][Full Text] [Related]
23. Effects of low dose omeprazole on gastric secretion and plasma gastrin in patients with healed duodenal ulcer.
Howden CW; Derodra JK; Burget DW; Hunt RH
Hepatogastroenterology; 1986 Dec; 33(6):267-70. PubMed ID: 3804185
[TBL] [Abstract][Full Text] [Related]
24. Gastric acid inhibitory profile of ebrotidine, a novel H2-receptor antagonist in humans.
Maczka M; Kwiecień N; Obtułowicz W; Konturek SJ; Kamiński K; Oleksy J; Gabryelewicz A; Torres J
J Physiol Pharmacol; 1992 Jun; 43(2):139-48. PubMed ID: 1356519
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
Okabe S; Shimosako K; Amagase K
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
[TBL] [Abstract][Full Text] [Related]
26. Relationship of omeprazole-induced hypergastrinemia to gastric pH.
Larson GM; Sullivan HW; Rayford PL
Surgery; 1986 Aug; 100(2):175-80. PubMed ID: 3738749
[TBL] [Abstract][Full Text] [Related]
27. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek JW
J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
[TBL] [Abstract][Full Text] [Related]
28. Omeprazole: its influence on gastric acid secretion, gastrin and ECL cells.
Larsson H; Håkanson R; Mattsson H; Ryberg B; Sundler F; Carlsson E
Toxicol Pathol; 1988; 16(2):267-72. PubMed ID: 3187355
[TBL] [Abstract][Full Text] [Related]
29. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
Abe Y; Inamori M; Togawa J; Kikuchi T; Muramatsu K; Chiguchi G; Kawamura H; Kobayashi N; Kirikoshi H; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
J Gastroenterol; 2004 Jan; 39(1):21-5. PubMed ID: 14767730
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
Batzri S; Brugada O; Harmon JW; Rich NM
J Pharmacol Exp Ther; 1988 Aug; 246(2):493-9. PubMed ID: 2841448
[TBL] [Abstract][Full Text] [Related]
31. [Effect of histamine H2-antagonists on serum gastrin levels in gastric lumen-perfused rats].
Yagita M
J UOEH; 1988 Jun; 10(2):189-201. PubMed ID: 2900546
[TBL] [Abstract][Full Text] [Related]
32. Effects of H2-receptor antagonists upon physiological acid secretory states in animals.
Pendleton RG; Cook PG; Shepherd-Rose A; Mangel AW
J Pharmacol Exp Ther; 1985 Apr; 233(1):64-9. PubMed ID: 2858583
[TBL] [Abstract][Full Text] [Related]
33. Effect of human gastrin-17 with and without acid suppression on human esophageal motility.
Allescher HD; Stoschus B; Wünsch E; Schusdziarra V; Classen M
Z Gastroenterol; 1995 Jul; 33(7):385-91. PubMed ID: 7571756
[TBL] [Abstract][Full Text] [Related]
34. Time course of inhibition of gastric acid secretion by omeprazole and ranitidine in gastric fistula rats.
Seensalu R; Girma K; Romell B; Nilsson G
Eur J Pharmacol; 1990 May; 180(1):145-52. PubMed ID: 2364999
[TBL] [Abstract][Full Text] [Related]
35. Effects of omeprazole and ranitidine on plasma gastrin concentration and stomach gastrin content in rats.
Seensalu R; Girma K; Romell B; Nilsson G
Ups J Med Sci; 1992; 97(2):157-67. PubMed ID: 1471315
[TBL] [Abstract][Full Text] [Related]
36. Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs.
Bersenas AM; Mathews KA; Allen DG; Conlon PD
Am J Vet Res; 2005 Mar; 66(3):425-31. PubMed ID: 15822586
[TBL] [Abstract][Full Text] [Related]
37. Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
Yuki H; Kamato T; Nishida A; Fujihara A; Takeda M; Miyata K
Jpn J Pharmacol; 1993 Nov; 63(3):345-51. PubMed ID: 7906319
[TBL] [Abstract][Full Text] [Related]
38. Effect of cimetidine, ranitidine, famotidine and omeprazole on hepatocyte proliferation in vitro.
Francavilla A; Panella C; Polimeno L; Di Leo A; Makowka L; Barone M; Amoruso A; Ingrosso M; Starzl TE
J Hepatol; 1989 Jan; 8(1):32-41. PubMed ID: 2564010
[TBL] [Abstract][Full Text] [Related]
39. Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin.
Smith JT; Gavey C; Nwokolo CU; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():47-63. PubMed ID: 1983346
[TBL] [Abstract][Full Text] [Related]
40. Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats.
Larsson H; Carlsson E; Håkanson R; Mattsson H; Nilsson G; Seensalu R; Wallmark B; Sundler F
Gastroenterology; 1988 Dec; 95(6):1477-86. PubMed ID: 3181674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
